Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome

Background Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically MLH1 -hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical oncology 2024-07, Vol.29 (7), p.953-963
Hauptverfasser: Ito, Tetsuya, Yamaguchi, Tatsuro, Kumamoto, Kensuke, Suzuki, Okihide, Chika, Noriyasu, Kawakami, Satoru, Nagai, Tomonori, Igawa, Tsukasa, Fujiyoshi, Kenji, Akagi, Yoshito, Arai, Tomio, Akagi, Kiwamu, Eguchi, Hidetaka, Okazaki, Yasushi, Ishida, Hideyuki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 963
container_issue 7
container_start_page 953
container_title International journal of clinical oncology
container_volume 29
creator Ito, Tetsuya
Yamaguchi, Tatsuro
Kumamoto, Kensuke
Suzuki, Okihide
Chika, Noriyasu
Kawakami, Satoru
Nagai, Tomonori
Igawa, Tsukasa
Fujiyoshi, Kenji
Akagi, Yoshito
Arai, Tomio
Akagi, Kiwamu
Eguchi, Hidetaka
Okazaki, Yasushi
Ishida, Hideyuki
description Background Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically MLH1 -hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive. Methods We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors. Characterization of dMMR tumors were performed as loss of at least one of MMR proteins (MLH1, MSH2, MSH6, and PMS2), by immunohistochemistry, followed by MLH1 promotor methylation analysis and genetic testing for MMR genes where appropriate. Somatic variant analysis of MMR genes and whole exome sequencing (WES) were performed in patients with LLS. Results In total, the incidence of dMMR tumors was 5.9% (24/3609). The incidence of dMMR tumors and the proportion of the three categorized dMMR tumors varied considerably with different tumor types. One to three likely pathogenic/pathogenic somatic MMR gene variants were detected in 15 out of the 16 available LLS tumors. One patient each from 12 patients who gave consent to WES demonstrated non- MMR germline variants affect function ( POLQ or BRCA1 ). Conclusions Our data regarding the LS to LLS ratio would be useful for genetic counseling in patients who are suspected to have LS, though the genetic backgrounds for the pathogenesis of LLS need further investigation.
doi_str_mv 10.1007/s10147-024-02518-y
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11196295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3071639273</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-d03d8640e281f798a9a1abcb5dda719c800600185c7ca2cc16552dade606e9233</originalsourceid><addsrcrecordid>eNp9ksuO1DAQRSMEYh7wAyyQJTZsAraT2MkKoREMI7XEBtZWtV2Z9pDYjZ20lP_iA6l0D8NjwcKypTp16-FbFC8EfyM412-z4KLWJZc1nUa05fKoOBd1pUuttXxM76oWZadkc1Zc5HzHudCqkU-Ls6pVopGtOi9-3ATrHQaLDIJjYxzQzgMkZneQwE6YfJ68zSz2zGHvrccwsdHnESa7Ywn34AmOwfnJx5AZ2BRzZsEHZM73PaY1YZrHmPKxxFpt8qQEa8Kqe4tpHFb-AMlDmDLz4RCHAxIc2GYJdlcO_huyvASX4ojPiic9DBmf39-XxdePH75cfSo3n69vrt5vSltLNZWOV65VNUfZil53LXQgYGu3jXOgRWdbzhXtpG2stiCtFapppAOHiivsZFVdFu9Ouvt5O6Kz1HiCweyTHyEtJoI3f0eC35nbeDBCCFp715DC63uFFL_PmCdDq7M4DBAwztlUvGpralYoQl_9g97FOQWajyhNQCf12pI8Ucc1J-wfuhHcrK4wJ1cYcoU5usIslPTyzzkeUn7ZgIDqBGQKBfqP37X_I_sTO23JWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3071639273</pqid></control><display><type>article</type><title>Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Ito, Tetsuya ; Yamaguchi, Tatsuro ; Kumamoto, Kensuke ; Suzuki, Okihide ; Chika, Noriyasu ; Kawakami, Satoru ; Nagai, Tomonori ; Igawa, Tsukasa ; Fujiyoshi, Kenji ; Akagi, Yoshito ; Arai, Tomio ; Akagi, Kiwamu ; Eguchi, Hidetaka ; Okazaki, Yasushi ; Ishida, Hideyuki</creator><creatorcontrib>Ito, Tetsuya ; Yamaguchi, Tatsuro ; Kumamoto, Kensuke ; Suzuki, Okihide ; Chika, Noriyasu ; Kawakami, Satoru ; Nagai, Tomonori ; Igawa, Tsukasa ; Fujiyoshi, Kenji ; Akagi, Yoshito ; Arai, Tomio ; Akagi, Kiwamu ; Eguchi, Hidetaka ; Okazaki, Yasushi ; Ishida, Hideyuki</creatorcontrib><description>Background Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically MLH1 -hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive. Methods We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors. Characterization of dMMR tumors were performed as loss of at least one of MMR proteins (MLH1, MSH2, MSH6, and PMS2), by immunohistochemistry, followed by MLH1 promotor methylation analysis and genetic testing for MMR genes where appropriate. Somatic variant analysis of MMR genes and whole exome sequencing (WES) were performed in patients with LLS. Results In total, the incidence of dMMR tumors was 5.9% (24/3609). The incidence of dMMR tumors and the proportion of the three categorized dMMR tumors varied considerably with different tumor types. One to three likely pathogenic/pathogenic somatic MMR gene variants were detected in 15 out of the 16 available LLS tumors. One patient each from 12 patients who gave consent to WES demonstrated non- MMR germline variants affect function ( POLQ or BRCA1 ). Conclusions Our data regarding the LS to LLS ratio would be useful for genetic counseling in patients who are suspected to have LS, though the genetic backgrounds for the pathogenesis of LLS need further investigation.</description><identifier>ISSN: 1341-9625</identifier><identifier>ISSN: 1437-7772</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-024-02518-y</identifier><identifier>PMID: 38615286</identifier><language>eng</language><publisher>Singapore: Springer Nature Singapore</publisher><subject>Adult ; Aged ; Bladder cancer ; BRCA1 protein ; Cancer ; Cancer Research ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms, Hereditary Nonpolyposis - genetics ; Colorectal Neoplasms, Hereditary Nonpolyposis - pathology ; DNA Methylation ; DNA Mismatch Repair - genetics ; DNA repair ; Endometrial cancer ; Exome Sequencing ; Female ; Gastric cancer ; Genetic analysis ; Genetic counseling ; Genetic disorders ; Genetic screening ; Germ-Line Mutation ; Humans ; Immunohistochemistry ; Incidence ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Mismatch repair ; MLH1 protein ; MSH2 protein ; MSH6 protein ; MutL Protein Homolog 1 - genetics ; Oncology ; Original ; Original Article ; Ovarian cancer ; Prostate cancer ; Solid tumors ; Surgical Oncology ; Tumors ; Urinary bladder ; Urinary tract ; Uterine cancer ; Whole genome sequencing</subject><ispartof>International journal of clinical oncology, 2024-07, Vol.29 (7), p.953-963</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c426t-d03d8640e281f798a9a1abcb5dda719c800600185c7ca2cc16552dade606e9233</cites><orcidid>0000-0002-1689-0963</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10147-024-02518-y$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10147-024-02518-y$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38615286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ito, Tetsuya</creatorcontrib><creatorcontrib>Yamaguchi, Tatsuro</creatorcontrib><creatorcontrib>Kumamoto, Kensuke</creatorcontrib><creatorcontrib>Suzuki, Okihide</creatorcontrib><creatorcontrib>Chika, Noriyasu</creatorcontrib><creatorcontrib>Kawakami, Satoru</creatorcontrib><creatorcontrib>Nagai, Tomonori</creatorcontrib><creatorcontrib>Igawa, Tsukasa</creatorcontrib><creatorcontrib>Fujiyoshi, Kenji</creatorcontrib><creatorcontrib>Akagi, Yoshito</creatorcontrib><creatorcontrib>Arai, Tomio</creatorcontrib><creatorcontrib>Akagi, Kiwamu</creatorcontrib><creatorcontrib>Eguchi, Hidetaka</creatorcontrib><creatorcontrib>Okazaki, Yasushi</creatorcontrib><creatorcontrib>Ishida, Hideyuki</creatorcontrib><title>Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><addtitle>Int J Clin Oncol</addtitle><description>Background Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically MLH1 -hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive. Methods We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors. Characterization of dMMR tumors were performed as loss of at least one of MMR proteins (MLH1, MSH2, MSH6, and PMS2), by immunohistochemistry, followed by MLH1 promotor methylation analysis and genetic testing for MMR genes where appropriate. Somatic variant analysis of MMR genes and whole exome sequencing (WES) were performed in patients with LLS. Results In total, the incidence of dMMR tumors was 5.9% (24/3609). The incidence of dMMR tumors and the proportion of the three categorized dMMR tumors varied considerably with different tumor types. One to three likely pathogenic/pathogenic somatic MMR gene variants were detected in 15 out of the 16 available LLS tumors. One patient each from 12 patients who gave consent to WES demonstrated non- MMR germline variants affect function ( POLQ or BRCA1 ). Conclusions Our data regarding the LS to LLS ratio would be useful for genetic counseling in patients who are suspected to have LS, though the genetic backgrounds for the pathogenesis of LLS need further investigation.</description><subject>Adult</subject><subject>Aged</subject><subject>Bladder cancer</subject><subject>BRCA1 protein</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms, Hereditary Nonpolyposis - genetics</subject><subject>Colorectal Neoplasms, Hereditary Nonpolyposis - pathology</subject><subject>DNA Methylation</subject><subject>DNA Mismatch Repair - genetics</subject><subject>DNA repair</subject><subject>Endometrial cancer</subject><subject>Exome Sequencing</subject><subject>Female</subject><subject>Gastric cancer</subject><subject>Genetic analysis</subject><subject>Genetic counseling</subject><subject>Genetic disorders</subject><subject>Genetic screening</subject><subject>Germ-Line Mutation</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Incidence</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Mismatch repair</subject><subject>MLH1 protein</subject><subject>MSH2 protein</subject><subject>MSH6 protein</subject><subject>MutL Protein Homolog 1 - genetics</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Ovarian cancer</subject><subject>Prostate cancer</subject><subject>Solid tumors</subject><subject>Surgical Oncology</subject><subject>Tumors</subject><subject>Urinary bladder</subject><subject>Urinary tract</subject><subject>Uterine cancer</subject><subject>Whole genome sequencing</subject><issn>1341-9625</issn><issn>1437-7772</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9ksuO1DAQRSMEYh7wAyyQJTZsAraT2MkKoREMI7XEBtZWtV2Z9pDYjZ20lP_iA6l0D8NjwcKypTp16-FbFC8EfyM412-z4KLWJZc1nUa05fKoOBd1pUuttXxM76oWZadkc1Zc5HzHudCqkU-Ls6pVopGtOi9-3ATrHQaLDIJjYxzQzgMkZneQwE6YfJ68zSz2zGHvrccwsdHnESa7Ywn34AmOwfnJx5AZ2BRzZsEHZM73PaY1YZrHmPKxxFpt8qQEa8Kqe4tpHFb-AMlDmDLz4RCHAxIc2GYJdlcO_huyvASX4ojPiic9DBmf39-XxdePH75cfSo3n69vrt5vSltLNZWOV65VNUfZil53LXQgYGu3jXOgRWdbzhXtpG2stiCtFapppAOHiivsZFVdFu9Ouvt5O6Kz1HiCweyTHyEtJoI3f0eC35nbeDBCCFp715DC63uFFL_PmCdDq7M4DBAwztlUvGpralYoQl_9g97FOQWajyhNQCf12pI8Ucc1J-wfuhHcrK4wJ1cYcoU5usIslPTyzzkeUn7ZgIDqBGQKBfqP37X_I_sTO23JWA</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Ito, Tetsuya</creator><creator>Yamaguchi, Tatsuro</creator><creator>Kumamoto, Kensuke</creator><creator>Suzuki, Okihide</creator><creator>Chika, Noriyasu</creator><creator>Kawakami, Satoru</creator><creator>Nagai, Tomonori</creator><creator>Igawa, Tsukasa</creator><creator>Fujiyoshi, Kenji</creator><creator>Akagi, Yoshito</creator><creator>Arai, Tomio</creator><creator>Akagi, Kiwamu</creator><creator>Eguchi, Hidetaka</creator><creator>Okazaki, Yasushi</creator><creator>Ishida, Hideyuki</creator><general>Springer Nature Singapore</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1689-0963</orcidid></search><sort><creationdate>202407</creationdate><title>Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome</title><author>Ito, Tetsuya ; Yamaguchi, Tatsuro ; Kumamoto, Kensuke ; Suzuki, Okihide ; Chika, Noriyasu ; Kawakami, Satoru ; Nagai, Tomonori ; Igawa, Tsukasa ; Fujiyoshi, Kenji ; Akagi, Yoshito ; Arai, Tomio ; Akagi, Kiwamu ; Eguchi, Hidetaka ; Okazaki, Yasushi ; Ishida, Hideyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-d03d8640e281f798a9a1abcb5dda719c800600185c7ca2cc16552dade606e9233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Bladder cancer</topic><topic>BRCA1 protein</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms, Hereditary Nonpolyposis - genetics</topic><topic>Colorectal Neoplasms, Hereditary Nonpolyposis - pathology</topic><topic>DNA Methylation</topic><topic>DNA Mismatch Repair - genetics</topic><topic>DNA repair</topic><topic>Endometrial cancer</topic><topic>Exome Sequencing</topic><topic>Female</topic><topic>Gastric cancer</topic><topic>Genetic analysis</topic><topic>Genetic counseling</topic><topic>Genetic disorders</topic><topic>Genetic screening</topic><topic>Germ-Line Mutation</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Incidence</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Mismatch repair</topic><topic>MLH1 protein</topic><topic>MSH2 protein</topic><topic>MSH6 protein</topic><topic>MutL Protein Homolog 1 - genetics</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Ovarian cancer</topic><topic>Prostate cancer</topic><topic>Solid tumors</topic><topic>Surgical Oncology</topic><topic>Tumors</topic><topic>Urinary bladder</topic><topic>Urinary tract</topic><topic>Uterine cancer</topic><topic>Whole genome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Tetsuya</creatorcontrib><creatorcontrib>Yamaguchi, Tatsuro</creatorcontrib><creatorcontrib>Kumamoto, Kensuke</creatorcontrib><creatorcontrib>Suzuki, Okihide</creatorcontrib><creatorcontrib>Chika, Noriyasu</creatorcontrib><creatorcontrib>Kawakami, Satoru</creatorcontrib><creatorcontrib>Nagai, Tomonori</creatorcontrib><creatorcontrib>Igawa, Tsukasa</creatorcontrib><creatorcontrib>Fujiyoshi, Kenji</creatorcontrib><creatorcontrib>Akagi, Yoshito</creatorcontrib><creatorcontrib>Arai, Tomio</creatorcontrib><creatorcontrib>Akagi, Kiwamu</creatorcontrib><creatorcontrib>Eguchi, Hidetaka</creatorcontrib><creatorcontrib>Okazaki, Yasushi</creatorcontrib><creatorcontrib>Ishida, Hideyuki</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Tetsuya</au><au>Yamaguchi, Tatsuro</au><au>Kumamoto, Kensuke</au><au>Suzuki, Okihide</au><au>Chika, Noriyasu</au><au>Kawakami, Satoru</au><au>Nagai, Tomonori</au><au>Igawa, Tsukasa</au><au>Fujiyoshi, Kenji</au><au>Akagi, Yoshito</au><au>Arai, Tomio</au><au>Akagi, Kiwamu</au><au>Eguchi, Hidetaka</au><au>Okazaki, Yasushi</au><au>Ishida, Hideyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome</atitle><jtitle>International journal of clinical oncology</jtitle><stitle>Int J Clin Oncol</stitle><addtitle>Int J Clin Oncol</addtitle><date>2024-07</date><risdate>2024</risdate><volume>29</volume><issue>7</issue><spage>953</spage><epage>963</epage><pages>953-963</pages><issn>1341-9625</issn><issn>1437-7772</issn><eissn>1437-7772</eissn><abstract>Background Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically MLH1 -hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive. Methods We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors. Characterization of dMMR tumors were performed as loss of at least one of MMR proteins (MLH1, MSH2, MSH6, and PMS2), by immunohistochemistry, followed by MLH1 promotor methylation analysis and genetic testing for MMR genes where appropriate. Somatic variant analysis of MMR genes and whole exome sequencing (WES) were performed in patients with LLS. Results In total, the incidence of dMMR tumors was 5.9% (24/3609). The incidence of dMMR tumors and the proportion of the three categorized dMMR tumors varied considerably with different tumor types. One to three likely pathogenic/pathogenic somatic MMR gene variants were detected in 15 out of the 16 available LLS tumors. One patient each from 12 patients who gave consent to WES demonstrated non- MMR germline variants affect function ( POLQ or BRCA1 ). Conclusions Our data regarding the LS to LLS ratio would be useful for genetic counseling in patients who are suspected to have LS, though the genetic backgrounds for the pathogenesis of LLS need further investigation.</abstract><cop>Singapore</cop><pub>Springer Nature Singapore</pub><pmid>38615286</pmid><doi>10.1007/s10147-024-02518-y</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1689-0963</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1341-9625
ispartof International journal of clinical oncology, 2024-07, Vol.29 (7), p.953-963
issn 1341-9625
1437-7772
1437-7772
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11196295
source MEDLINE; SpringerLink Journals
subjects Adult
Aged
Bladder cancer
BRCA1 protein
Cancer
Cancer Research
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms, Hereditary Nonpolyposis - genetics
Colorectal Neoplasms, Hereditary Nonpolyposis - pathology
DNA Methylation
DNA Mismatch Repair - genetics
DNA repair
Endometrial cancer
Exome Sequencing
Female
Gastric cancer
Genetic analysis
Genetic counseling
Genetic disorders
Genetic screening
Germ-Line Mutation
Humans
Immunohistochemistry
Incidence
Male
Medicine
Medicine & Public Health
Middle Aged
Mismatch repair
MLH1 protein
MSH2 protein
MSH6 protein
MutL Protein Homolog 1 - genetics
Oncology
Original
Original Article
Ovarian cancer
Prostate cancer
Solid tumors
Surgical Oncology
Tumors
Urinary bladder
Urinary tract
Uterine cancer
Whole genome sequencing
title Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A21%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20molecular%20characteristics%20of%20deficient%20mismatch%20repair%20conditions%20across%20nine%20different%20tumors%20and%20identification%20of%20germline%20variants%20involved%20in%20Lynch-like%20syndrome&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=Ito,%20Tetsuya&rft.date=2024-07&rft.volume=29&rft.issue=7&rft.spage=953&rft.epage=963&rft.pages=953-963&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-024-02518-y&rft_dat=%3Cproquest_pubme%3E3071639273%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3071639273&rft_id=info:pmid/38615286&rfr_iscdi=true